Ospedale Regionale Bellinzona e Valli ( Site 0104) — Bellinzona, Canton Ticino

Public research footprint of Ospedale Regionale Bellinzona e Valli ( Site 0104), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced Solid Tumors · Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) · Relapsed/Refractory Non-Hodgkin Lymphoma · TNBC - Triple-Negative Breast Cancer

Recently updated registry entries

NCT07318558 — A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer… (Recruiting)
NCT07600749 — Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors… (Recruiting)
NCT05067283 — A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001) (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Ospedale Regionale Bellinzona e Valli ( Site 0104)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.